Aurinia Pharmaceuticals AUPH Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's common stock, shares issued (in shares)?
- Aurinia Pharmaceuticals (AUPH) reported common stock, shares issued (in shares) of $130.77M in Q1 2026.
- How has Aurinia Pharmaceuticals's common stock, shares issued (in shares) changed year-over-year?
- Aurinia Pharmaceuticals's common stock, shares issued (in shares) decreased by 5.1% year-over-year, from $137.75M to $130.77M.
- What is the long-term trend for Aurinia Pharmaceuticals's common stock, shares issued (in shares)?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's common stock, shares issued (in shares) has grown at a 0.9% compound annual growth rate (CAGR), from $126.73M to $132.32M.